ELDN - Eledon Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ELDN is currently covered by 2 analysts with an average price target of $15.25. This is a potential upside of $11.77 (338.22%) from yesterday's end of day stock price of $3.48.

Eledon Pharmaceuticals's activity chart (see below) currently has 2 price targets and 13 ratings on display. The stock rating distribution of ELDN is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ELDN is $16, Lowest price target is $9, average price target is $12.5.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 01-Sep-2025. First documented stock forecast 07-Feb-2021.

Best performing analysts who are covering ELDN - Eledon Pharmaceuticals:

Thomas Smith Alethia Young Vernon Bernardino Yi Chen

Currently out of the existing stock ratings of ELDN, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$9

$5.52 (158.62%)

$9

1 months 25 days ago
(01-Sep-2025)

0/2 (0%)

$6.45 (252.94%)

Buy

$16

$12.52 (359.77%)

11 months 7 days ago
(19-Nov-2024)

0/2 (0%)

$12.15 (315.58%)

Buy

3 years 4 months 26 days ago
(31-May-2022)

0/1 (0%)

$16.69 (96.42%)

Buy

$25

$22.35 (843.40%)

4 years 7 months 3 days ago
(23-Mar-2021)

0/1 (0%)

$11.78 (89.11%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ELDN (Eledon Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ELDN (Eledon Pharmaceuticals) with a proven track record?

THOMAS SMITH

Which analyst has the current lower performing score on ELDN (Eledon Pharmaceuticals) with a proven track record?

YI CHEN

Which analyst has the most public recommendations on ELDN (Eledon Pharmaceuticals)?

Thomas Smith has 3 price targets and 3 ratings on ELDN

Which analyst is the currently most bullish on ELDN (Eledon Pharmaceuticals)?

Alethia Young with highest potential upside - $22.35

Which analyst is the currently most reserved on ELDN (Eledon Pharmaceuticals)?

Thomas Smith with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?